Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Sequence analysis of the IL28A/IL28B inverted gene duplication that contains polymorphisms associated with treatment response in hepatitis C patients.

Reynolds JM, Paciga SA, Sanders FA, Hyde CL, Loomis AK, Johnston GI.

PLoS One. 2012;7(1):e29983. doi: 10.1371/journal.pone.0029983. Epub 2012 Jan 10.

2.

IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?

Orlent H, Reynaert H, Bourgeois S, Dideberg V, Adler M, Colle I, De Maeght S, Laleman W, Michielsen P, Moreno C, Mulkay JP, Stärkel P, Delwaide J; Belgian Association for the Study of the Liver.

Acta Gastroenterol Belg. 2011 Jun;74(2):317-22. Review.

3.

Genetics of IL28B and HCV--response to infection and treatment.

Hayes CN, Imamura M, Aikata H, Chayama K.

Nat Rev Gastroenterol Hepatol. 2012 May 29;9(7):406-17. doi: 10.1038/nrgastro.2012.101. Review.

PMID:
22641049
4.

Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients.

Mangia A, Mottola L, Santoro R.

World J Gastroenterol. 2013 Dec 21;19(47):8924-8. doi: 10.3748/wjg.v19.i47.8924. Review.

5.

IL28B single nucleotide polymorphisms in the treatment of hepatitis C.

Lange CM, Zeuzem S.

J Hepatol. 2011 Sep;55(3):692-701. doi: 10.1016/j.jhep.2011.03.006. Epub 2011 Mar 25. Review.

Supplemental Content

Support Center